Literature DB >> 7996141

Identification of a second protein encoded by influenza C virus RNA segment 6.

S Hongo1, K Sugawara, H Nishimura, Y Muraki, F Kitame, K Nakamura.   

Abstract

Influenza C virus matrix protein (M1) is encoded by a spliced mRNA derived from RNA segment 6. Unspliced mRNA from this RNA segment, which has not been previously identified, can potentially encode a polypeptide that contains an additional 132 amino acids on the carboxy terminus of the M1 protein. Here the nucleotide sequences of RNA segment 6 of four influenza C strains, isolated in Japan between 1964 and 1988, were compared with the previously determined sequence of C/Ann Arbor/1/50. The results indicated that the deduced amino acid sequence of the carboxy-terminal 132 amino acid domain is conserved fairly well although it is more divergent than the M1 protein sequence. Examination of RNA segment 6-specific mRNAs also showed that unspliced mRNA is present, although in small quantities (approximately 13% of spliced mRNA), in influenza C virus-infected cells. To search for a polypeptide encoded by the unspliced mRNA, the extra carboxy-terminal domain was expressed in Escherichia coli as the glutathione S-transferase fusion protein, and rabbit immune serum was raised against the purified fusion protein. Immunoprecipitation experiments with this antiserum revealed that a previously unrecognized protein of apparent M(r) approximately 18,000, designated CM2, is synthesized in influenza C virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996141     DOI: 10.1099/0022-1317-75-12-3503

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Mapping the energy surface of transmembrane helix-helix interactions.

Authors:  J Torres; A Kukol; I T Arkin
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

3.  Role of the CM2 protein in the influenza C virus replication cycle.

Authors:  Takatoshi Furukawa; Yasushi Muraki; Takeshi Noda; Emi Takashita; Ri Sho; Kanetsu Sugawara; Yoko Matsuzaki; Yoshitaka Shimotai; Seiji Hongo
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

4.  Characterization of a second protein (CM2) encoded by RNA segment 6 of influenza C virus.

Authors:  S Hongo; K Sugawara; Y Muraki; F Kitame; K Nakamura
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Effect of Phosphorylation of CM2 Protein on Influenza C Virus Replication.

Authors:  Takanari Goto; Yoshitaka Shimotai; Yoko Matsuzaki; Yasushi Muraki; Ri Sho; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

6.  NS1 protein of influenza A virus down-regulates apoptosis.

Authors:  O P Zhirnov; T E Konakova; T Wolff; H-D Klenk
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Evolutionary analysis of influenza C virus M genes.

Authors:  Y Tada; S Hongo; Y Muraki; K Sugawara; F Kitame; K Nakamura
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

8.  Influenza C virus NS1 protein upregulates the splicing of viral mRNAs.

Authors:  Yasushi Muraki; Takatoshi Furukawa; Yoshihiko Kohno; Yoko Matsuzaki; Emi Takashita; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Influenza C virus CM2 protein is produced from a 374-amino-acid protein (P42) by signal peptidase cleavage.

Authors:  S Hongo; K Sugawara; Y Muraki; Y Matsuzaki; E Takashita; F Kitame; K Nakamura
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence.

Authors:  A Pekosz; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.